AstraZeneca: New study shows anti-body drug effective vs. Omicron variants

  • 📰 gmanews
  • ⏱ Reading Time:
  • 26 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 68%

Philippines Headlines News

Philippines Latest News,Philippines Headlines

Drug firm AstraZeneca reported good results from the latest trial of its COVID-19 antibody medication against the Omicron variant.

The firm cited a new study from the Washington University School of Medicine which showed AZD7442 maintained the effective resistance against Omicron variant, including its sub-variants BA.1, BA.1.1 and BA.2.1.

in individuals with weak immune systems or a history of severe side effects from coronavirus vaccines. John Perez, senior vice president, Head of Late Development, Vaccines & Immune Therapies of AstraZeneca, said the data showed that AZD7442 reduced viral burden and limited inflammation caused by Omicron.

The US national public health agency said on Monday the BA.2 sub-variant of Omicron was estimated to account for nearly three of every four coronavirus variants in the country.

Source: Education Headlines (educationheadlines.net)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 11. in PH

Philippines Latest News, Philippines Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Current vaccines still effective vs. 'Omicron XE' –expertThe COVID-19 vaccines currently administered in the country still remain effective against the possible new coronavirus variant linked to the more transmissible Omicron, infectious disease expert Dr. Rontgene Solante said Tuesday. Hindi yan effective against the virus eversince, dahil hindi naman virus ang pinatay nyan kundi pinapraktice lang ang katawan ng tao mag response kung may totoong virus na pumapasok sa katawan. It's gene theraphy, not a true vaccine.
Source: gmanews - 🏆 11. / 68 Read more »

DOH monitoring 'Omicron XE' after a reported case in ThailandThe Department of Health said that it was in constant coordination with the World Health Organization (WHO) following a reported case of Omicron XE – a recombinant of Omicron subvariants BA.1 and BA.2 – in Bangkok, Thailand. Hanggat si TEDROS ang WHO head, hindi mawawala ang covid. Lahat ng variant ilalatag nyan, tuta rin ni Xi Jinping yan.
Source: rapplerdotcom - 🏆 4. / 86 Read more »

Expert: Omicron XE may be more transmissible but can’t dodge vax efficacyAN EXPERT said Tuesday, April 5, 2022, that the reported recombinant of the two Omicron variant sub-lineages, initially called “XE,” may be more transmissible than Omicron...
Source: sunstaronline - 🏆 18. / 59 Read more »

South Korea’s daily infections jump to over 260,000South Korea’s new coronavirus cases jumped to over 260,000 on Tuesday as the spread of the Omicron variant slowed down after peaking out last month. | asianewsnetwork
Source: inquirerdotnet - 🏆 3. / 86 Read more »

DOH coordinating with WHO regarding 'Omicron XE'The Department of Health (DOH) on Monday said it is in constant coordination with the World Health Organization (WHO) regarding XE, a possible new coronavirus variant linked to the more transmissible Omicron. Thejasperjanboy punyeta... DOHgovph
Source: gmanews - 🏆 11. / 68 Read more »

Omicron sub-variant BA.2 makes up 72% of COVID variants in US — CDCThe US national public health agency said on Monday the BA.2 sub-variant of Omicron was estimated to account for nearly three of every four coronavirus variants in the country.  
Source: gmanews - 🏆 11. / 68 Read more »